Cochrane · systematic review · CD010960
Injection therapies for Achilles tendinopathy
Kearney, RS, Parsons, N, Metcalfe, D, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Bone, Joint and Muscle TraumaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 4 · 57.1%Low 3 · 42.9%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings: Injection therapies versus placebo or no injection control
Population: individuals with an investigator‐reported diagnosis of Achilles tendinopathy (or related terminology, e.g. tendinitis). We excluded trials focusing on the treatment of individuals with systemic conditions (e.g. rheumatoid arthritis and diabetes)1
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
VISA‐A (score 0 to 100; 100 = no problems) At 6 weeks Summary of findings: Injection therapies vs placebo or no injection control | MD 0.79 | 5 studies · 200 participants | Low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
VISA‐A (score 0 to 100; 100 = no problems) At 3 months Summary of findings: Injection therapies vs placebo or no injection control | no estimate extracted | 5 studies · 189 participants | Low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
VISA‐A (score 0 to 100; 100 = no problems) After 3 months (6 to 12 months) Summary of findings: Injection therapies vs placebo or no injection control | MD 0.14 | 3 studies · 132 participants | Low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Adverse events At final Summary of findings: Injection therapies vs placebo or no injection control | RR 0.97 [0.5, 1.89] | 13 studies · 449 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Pain (VAS; score 0 to 100; 0 = no pain) Summary of findings: Injection therapies vs placebo or no injection control | no estimate extracted | 7 studies · 219 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Return to sports At final Summary of findings: Injection therapies vs placebo or no injection control | RR 1.39 [1, 1.94] | 7 studies · 335 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Patient satisfaction (number of participants satisfied with their treatment) At final Summary of findings: Injection therapies vs placebo or no injection control | RR 1.05 [0.76, 1.47] | 4 studies · 152 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness |